A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation
Objectives: This study aimed to evaluate and compare local tolerability of investigational drug TV-46046 and reference drug Depo-subQ Provera 104, both containing medroxyprogesterone acetate (MPA) as an active ingredient. Study design: We conducted a randomized, crossover, single-center study. Twent...
Main Authors: | Vera Halpern, Angie Wheeless, Vivian Brache, Anja Lendvay, Leila Cochón, Douglas Taylor, Laneta J. Dorflinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Contraception: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590151623000126 |
Similar Items
-
Sexual Dysfunction in Two Types of Hormonal Contraception: Combined Oral Contraceptives versus Depot Medroxyprogesterone Acetate
by: Nourossadat Kariman, et al.
Published: (2017-01-01) -
Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: a multicenter phase 3 trial
by: Jennifer Deese, et al.
Published: (2022-02-01) -
Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review
by: Adeniyi Kolade Aderoba, et al.
Published: (2023-07-01) -
Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review
by: P. Silva, et al.
Published: (2018-04-01) -
Effects of Depot Medroxyprogesterone Acetate Intramuscular Injection, Copper Intrauterine Device and Levonorgestrel Implant Contraception on Estradiol Levels: An Ancillary Study of the ECHO Randomized Trial
by: Rebecca Ryan, et al.
Published: (2022-05-01)